RecruitingNCT04478305
Study of hormone therapy and mood around menopause
About this title
Read the official source — NCT04478305This study assesses depression symptoms.
Medication studyAges 45–60CanadaAnxiety
Understand this study
What is this study about?
This study assesses depression symptoms.
Who could participate?
Listed age limits: 45 years to 60 years.
- Listed locations
- HamiltonSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 3, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 30
- Sponsor
- St. Joseph's Healthcare Hamilton
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- Canada
- Age range
- From 45 Years to 60 Years
- Official registry ID
- NCT04478305
- Official title
Show the full official title
The Effect of Conjugated Estrogens/ Bazedoxifene (CE/ BZA) on Peri- and Postmenopausal Mood and Anxiety Symptoms: A Pilot Study
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Hamilton
Interested in joining this study?
Questions about this study
What is this study about?
This study assesses depression symptoms.
Who is behind this study?
The study sponsor is St. Joseph's Healthcare Hamilton.
Does this study involve medication?
Yes. The study involves medication, including Duavive 0.45Mg-20Mg Tablet.
Who can participate?
Listed age limits: 45 years to 60 years.
Is this study still recruiting?
The registry lists this study as recruiting.
